39
to know ... Objective is ...... WHAT are clinical trials ?

Clinical trials

Embed Size (px)

DESCRIPTION

an easy introduction

Citation preview

Page 1: Clinical trials

to know ...

Objective is......

WHATare clinical trials?

Page 2: Clinical trials

I have discovered a drug and my object is

to market it to

make...

Page 3: Clinical trials

$money$

Page 4: Clinical trials
Page 5: Clinical trials

FDA

But

wont let you do it

Page 6: Clinical trials

But... Why...?

Page 7: Clinical trials

because FDA is not sure whether your drug is

SAFE &EFFECTIV

E

Page 8: Clinical trials

But how do I convince FDA thatmy drug is ...

...SAFE & EFFECTIVE ?

Page 9: Clinical trials

By bringing evidencethroughCLINICAL TRIALS!

Page 10: Clinical trials

But wait!First you have to doPRE clinicalTrials!

Page 11: Clinical trials

before human testing is permitted

i.e. Testing on animals

Page 12: Clinical trials

To know if this drug is relatively safe to be tested

in humans

For this acute, sub acute and

chronic toxicities are

studied

Page 13: Clinical trials

to know probable therapeutic action....

What?

Where?

Page 14: Clinical trials

to know pharmacokinetics

What happens to drug in the bodyand how?

Page 15: Clinical trials

It takes about two yearsOn averege......gives data on

SafetyToxicityPharmacodynamicsPharmacoknetics

Page 16: Clinical trials

But Congratulations now you can file for

Page 17: Clinical trials

Now is the time to start Clinical Trials...

Page 18: Clinical trials

General Process followed in clinical trial

Page 19: Clinical trials

Phase 1

Page 20: Clinical trials

bring the humanvolunteersnow... about the size of ...

Page 21: Clinical trials

this class room

i.e. 30-50 approx

Page 22: Clinical trials

healthy volunteers!

Page 23: Clinical trials

Collect data on

dose response relationshipsafe dosage rangeacute effects over rangeside effects

Page 24: Clinical trials

Phase 2

Page 25: Clinical trials

done on patients

Page 26: Clinical trials

hundreds of people

approx 100-300

Page 27: Clinical trials

Question is...Whether the PATIENT has the desired therapeutic effects at

doses that are tolerated by sickpatients?

Page 28: Clinical trials

Single blinded or double blindedcontrolled study

Page 29: Clinical trials

Phase 3

Page 30: Clinical trials

In about1000-5000

people

Page 31: Clinical trials

Question is...Whether the drug works in the

manner proposed for its ULTIMATE GENERAL USE?

Page 32: Clinical trials

Explore

further beneficial actions

toxicities

compare with older therapies

Page 33: Clinical trials

With all this info on NDA FDA evaluate

a drug and takes decision on approval

Page 34: Clinical trials

Phase 4

Page 35: Clinical trials

Used by masses

Page 36: Clinical trials

POST MARKETING SURVEILLANCE

Market it for the masses to be used as prescription drug

and then watch closely

to prevent major therapeutic disasters/

find outinfrequent side effects.

Page 37: Clinical trials

It takes about 8 to10 years on averege but finally

Page 38: Clinical trials

Patent for20 years

Page 39: Clinical trials